nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAP2K5—restless legs syndrome	0.868	1	CbGaD
Nilotinib—EPHB3—nerve—restless legs syndrome	0.00353	0.0394	CbGeAlD
Nilotinib—EPHA4—nerve—restless legs syndrome	0.00295	0.0329	CbGeAlD
Nilotinib—EPHB2—brainstem—restless legs syndrome	0.0023	0.0257	CbGeAlD
Nilotinib—MAP4K1—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.00198	0.0467	CbGpPWpGaD
Nilotinib—MAPK8—brainstem—restless legs syndrome	0.00184	0.0205	CbGeAlD
Nilotinib—EPHB3—EPHB forward signaling—TF—restless legs syndrome	0.00183	0.0433	CbGpPWpGaD
Nilotinib—CA1—nerve—restless legs syndrome	0.00163	0.0183	CbGeAlD
Nilotinib—BRAF—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.00159	0.0376	CbGpPWpGaD
Nilotinib—EPHB4—EPHB forward signaling—TF—restless legs syndrome	0.00156	0.0368	CbGpPWpGaD
Nilotinib—EPHB3—brainstem—restless legs syndrome	0.00151	0.0169	CbGeAlD
Nilotinib—EPHB2—EPHB forward signaling—TF—restless legs syndrome	0.00151	0.0356	CbGpPWpGaD
Nilotinib—MAPK8—Circadian rythm related genes—BTBD9—restless legs syndrome	0.00144	0.034	CbGpPWpGaD
Nilotinib—MAPK8—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.00137	0.0325	CbGpPWpGaD
Nilotinib—CA4—nerve—restless legs syndrome	0.00128	0.0143	CbGeAlD
Nilotinib—EPHA4—brainstem—restless legs syndrome	0.00126	0.0141	CbGeAlD
Nilotinib—CDC42BPB—spinal cord—restless legs syndrome	0.00126	0.0141	CbGeAlD
Nilotinib—EPHB2—nervous system—restless legs syndrome	0.0012	0.0135	CbGeAlD
Nilotinib—CSF1R—Differentiation Pathway—TF—restless legs syndrome	0.00118	0.0278	CbGpPWpGaD
Nilotinib—MAPK14—brainstem—restless legs syndrome	0.00117	0.013	CbGeAlD
Nilotinib—EPHB2—central nervous system—restless legs syndrome	0.00116	0.013	CbGeAlD
Nilotinib—EPHA8—nervous system—restless legs syndrome	0.00115	0.0129	CbGeAlD
Nilotinib—MAPK14—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.00115	0.0271	CbGpPWpGaD
Nilotinib—MAPK8—spinal cord—restless legs syndrome	0.00114	0.0128	CbGeAlD
Nilotinib—EPHA8—central nervous system—restless legs syndrome	0.00111	0.0124	CbGeAlD
Nilotinib—MAPK11—nervous system—restless legs syndrome	0.00107	0.012	CbGeAlD
Nilotinib—CDC42BPB—nervous system—restless legs syndrome	0.00106	0.0119	CbGeAlD
Nilotinib—MAPK11—central nervous system—restless legs syndrome	0.00103	0.0115	CbGeAlD
Nilotinib—CDC42BPB—central nervous system—restless legs syndrome	0.00102	0.0114	CbGeAlD
Nilotinib—EPHA3—nervous system—restless legs syndrome	0.00101	0.0113	CbGeAlD
Nilotinib—MAPK8—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.00098	0.0231	CbGpPWpGaD
Nilotinib—EPHA3—central nervous system—restless legs syndrome	0.000971	0.0109	CbGeAlD
Nilotinib—MAPK8—nervous system—restless legs syndrome	0.000962	0.0108	CbGeAlD
Nilotinib—EPHA6—nervous system—restless legs syndrome	0.000962	0.0108	CbGeAlD
Nilotinib—EPHB3—spinal cord—restless legs syndrome	0.000942	0.0105	CbGeAlD
Nilotinib—MAPK8—central nervous system—restless legs syndrome	0.000926	0.0104	CbGeAlD
Nilotinib—EPHA6—central nervous system—restless legs syndrome	0.000926	0.0104	CbGeAlD
Nilotinib—EPHB2—brain—restless legs syndrome	0.00092	0.0103	CbGeAlD
Nilotinib—LYN—nervous system—restless legs syndrome	0.000888	0.00992	CbGeAlD
Nilotinib—EPHA8—brain—restless legs syndrome	0.000882	0.00986	CbGeAlD
Nilotinib—HCK—spinal cord—restless legs syndrome	0.000865	0.00967	CbGeAlD
Nilotinib—MAP2K5—brainstem—restless legs syndrome	0.000865	0.00967	CbGeAlD
Nilotinib—LYN—central nervous system—restless legs syndrome	0.000855	0.00956	CbGeAlD
Nilotinib—MAP4K1—Insulin Signaling—MAP2K5—restless legs syndrome	0.000841	0.0199	CbGpPWpGaD
Nilotinib—TIE1—nervous system—restless legs syndrome	0.000834	0.00932	CbGeAlD
Nilotinib—MAP4K1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000833	0.0197	CbGpPWpGaD
Nilotinib—MAPK11—brain—restless legs syndrome	0.00082	0.00916	CbGeAlD
Nilotinib—MAPK8—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.00082	0.0193	CbGpPWpGaD
Nilotinib—CDC42BPB—brain—restless legs syndrome	0.000813	0.00909	CbGeAlD
Nilotinib—MAP4K1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000809	0.0191	CbGpPWpGaD
Nilotinib—TIE1—central nervous system—restless legs syndrome	0.000803	0.00898	CbGeAlD
Nilotinib—EPHB3—nervous system—restless legs syndrome	0.000794	0.00887	CbGeAlD
Nilotinib—BRAF—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000788	0.0186	CbGpPWpGaD
Nilotinib—MAPK14—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.000782	0.0185	CbGpPWpGaD
Nilotinib—EPHA3—brain—restless legs syndrome	0.000771	0.00862	CbGeAlD
Nilotinib—KIT—brainstem—restless legs syndrome	0.000766	0.00857	CbGeAlD
Nilotinib—EPHB3—central nervous system—restless legs syndrome	0.000764	0.00854	CbGeAlD
Nilotinib—MAPK8—brain—restless legs syndrome	0.000735	0.00822	CbGeAlD
Nilotinib—EPHA6—brain—restless legs syndrome	0.000735	0.00822	CbGeAlD
Nilotinib—HCK—nervous system—restless legs syndrome	0.000729	0.00815	CbGeAlD
Nilotinib—MAPK14—spinal cord—restless legs syndrome	0.000725	0.00811	CbGeAlD
Nilotinib—CA14—spinal cord—restless legs syndrome	0.000705	0.00788	CbGeAlD
Nilotinib—HCK—central nervous system—restless legs syndrome	0.000702	0.00785	CbGeAlD
Nilotinib—EPHB4—spinal cord—restless legs syndrome	0.000687	0.00768	CbGeAlD
Nilotinib—PDGFRA—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000679	0.016	CbGpPWpGaD
Nilotinib—LYN—brain—restless legs syndrome	0.000679	0.00759	CbGeAlD
Nilotinib—BRAF—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.000673	0.0159	CbGpPWpGaD
Nilotinib—MAP4K1—brain—restless legs syndrome	0.000668	0.00747	CbGeAlD
Nilotinib—ABL1—brainstem—restless legs syndrome	0.000667	0.00746	CbGeAlD
Nilotinib—EPHA4—nervous system—restless legs syndrome	0.000663	0.00741	CbGeAlD
Nilotinib—TEK—spinal cord—restless legs syndrome	0.000658	0.00735	CbGeAlD
Nilotinib—CA3—nervous system—restless legs syndrome	0.000655	0.00732	CbGeAlD
Nilotinib—BRAF—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.000647	0.0153	CbGpPWpGaD
Nilotinib—EPHA4—central nervous system—restless legs syndrome	0.000638	0.00713	CbGeAlD
Nilotinib—TIE1—brain—restless legs syndrome	0.000638	0.00713	CbGeAlD
Nilotinib—MAPK8—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000637	0.015	CbGpPWpGaD
Nilotinib—CA3—central nervous system—restless legs syndrome	0.00063	0.00704	CbGeAlD
Nilotinib—EPHB6—spinal cord—restless legs syndrome	0.000629	0.00703	CbGeAlD
Nilotinib—PDGFRB—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.000612	0.0144	CbGpPWpGaD
Nilotinib—BRAF—brain—restless legs syndrome	0.000611	0.00683	CbGeAlD
Nilotinib—MAPK14—nervous system—restless legs syndrome	0.000611	0.00683	CbGeAlD
Nilotinib—FGR—nervous system—restless legs syndrome	0.000609	0.0068	CbGeAlD
Nilotinib—EPHB3—brain—restless legs syndrome	0.000607	0.00678	CbGeAlD
Nilotinib—CA9—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.000598	0.0141	CbGpPWpGaD
Nilotinib—PDGFRA—spinal cord—restless legs syndrome	0.000596	0.00666	CbGeAlD
Nilotinib—MAPK14—central nervous system—restless legs syndrome	0.000588	0.00658	CbGeAlD
Nilotinib—KIT—Differentiation Pathway—TF—restless legs syndrome	0.000588	0.0139	CbGpPWpGaD
Nilotinib—FGR—central nervous system—restless legs syndrome	0.000586	0.00655	CbGeAlD
Nilotinib—MAPK8—Insulin Signaling—MAP2K5—restless legs syndrome	0.000585	0.0138	CbGpPWpGaD
Nilotinib—MAPK8—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000579	0.0137	CbGpPWpGaD
Nilotinib—EPHA2—nervous system—restless legs syndrome	0.000568	0.00635	CbGeAlD
Nilotinib—HCK—Focal Adhesion—MAP2K5—restless legs syndrome	0.000563	0.0133	CbGpPWpGaD
Nilotinib—MAPK8—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000563	0.0133	CbGpPWpGaD
Nilotinib—HCK—brain—restless legs syndrome	0.000557	0.00623	CbGeAlD
Nilotinib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.000557	0.0132	CbGpPWpGaD
Nilotinib—TEK—nervous system—restless legs syndrome	0.000554	0.0062	CbGeAlD
Nilotinib—ABL2—brain—restless legs syndrome	0.000554	0.00619	CbGeAlD
Nilotinib—CA4—brainstem—restless legs syndrome	0.000548	0.00612	CbGeAlD
Nilotinib—EPHA2—central nervous system—restless legs syndrome	0.000547	0.00612	CbGeAlD
Nilotinib—CA7—brain—restless legs syndrome	0.000545	0.0061	CbGeAlD
Nilotinib—MAP2K5—spinal cord—restless legs syndrome	0.000538	0.00601	CbGeAlD
Nilotinib—TEK—central nervous system—restless legs syndrome	0.000534	0.00597	CbGeAlD
Nilotinib—EPHB6—nervous system—restless legs syndrome	0.00053	0.00592	CbGeAlD
Nilotinib—CSF1R—spinal cord—restless legs syndrome	0.000525	0.00587	CbGeAlD
Nilotinib—EPHB6—central nervous system—restless legs syndrome	0.00051	0.0057	CbGeAlD
Nilotinib—MAPK8—Focal Adhesion—MAP2K5—restless legs syndrome	0.00051	0.012	CbGpPWpGaD
Nilotinib—BLK—Focal Adhesion—MAP2K5—restless legs syndrome	0.00051	0.012	CbGpPWpGaD
Nilotinib—FGR—Focal Adhesion—MAP2K5—restless legs syndrome	0.000508	0.012	CbGpPWpGaD
Nilotinib—EPHA4—brain—restless legs syndrome	0.000507	0.00566	CbGeAlD
Nilotinib—PDGFRA—nervous system—restless legs syndrome	0.000502	0.00561	CbGeAlD
Nilotinib—CA3—brain—restless legs syndrome	0.0005	0.00559	CbGeAlD
Nilotinib—PDGFRA—central nervous system—restless legs syndrome	0.000484	0.0054	CbGeAlD
Nilotinib—KIT—spinal cord—restless legs syndrome	0.000477	0.00533	CbGeAlD
Nilotinib—MAPK14—brain—restless legs syndrome	0.000467	0.00522	CbGeAlD
Nilotinib—MAPK11—Insulin Signaling—MAP2K5—restless legs syndrome	0.000466	0.011	CbGpPWpGaD
Nilotinib—PDGFRB—spinal cord—restless legs syndrome	0.000465	0.0052	CbGeAlD
Nilotinib—FGR—brain—restless legs syndrome	0.000465	0.0052	CbGeAlD
Nilotinib—CA12—nervous system—restless legs syndrome	0.000464	0.00518	CbGeAlD
Nilotinib—BRAF—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000457	0.0108	CbGpPWpGaD
Nilotinib—CA14—brain—restless legs syndrome	0.000454	0.00508	CbGeAlD
Nilotinib—CA2—brainstem—restless legs syndrome	0.000454	0.00508	CbGeAlD
Nilotinib—MAP2K5—nervous system—restless legs syndrome	0.000453	0.00506	CbGeAlD
Nilotinib—CA12—central nervous system—restless legs syndrome	0.000446	0.00499	CbGeAlD
Nilotinib—BRAF—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000444	0.0105	CbGpPWpGaD
Nilotinib—EPHB4—brain—restless legs syndrome	0.000443	0.00495	CbGeAlD
Nilotinib—CSF1R—nervous system—restless legs syndrome	0.000442	0.00494	CbGeAlD
Nilotinib—MAP2K5—central nervous system—restless legs syndrome	0.000436	0.00488	CbGeAlD
Nilotinib—CA1—spinal cord—restless legs syndrome	0.000436	0.00487	CbGeAlD
Nilotinib—EPHA2—brain—restless legs syndrome	0.000434	0.00485	CbGeAlD
Nilotinib—ABCG2—Iron uptake and transport—TF—restless legs syndrome	0.000426	0.0101	CbGpPWpGaD
Nilotinib—CSF1R—central nervous system—restless legs syndrome	0.000426	0.00476	CbGeAlD
Nilotinib—TEK—brain—restless legs syndrome	0.000424	0.00474	CbGeAlD
Nilotinib—ABL1—spinal cord—restless legs syndrome	0.000415	0.00464	CbGeAlD
Nilotinib—EPHB6—brain—restless legs syndrome	0.000405	0.00453	CbGeAlD
Nilotinib—BRAF—Focal Adhesion—MAP2K5—restless legs syndrome	0.000403	0.0095	CbGpPWpGaD
Nilotinib—KIT—nervous system—restless legs syndrome	0.000402	0.00449	CbGeAlD
Nilotinib—PDGFRB—nervous system—restless legs syndrome	0.000392	0.00438	CbGeAlD
Nilotinib—KIT—central nervous system—restless legs syndrome	0.000387	0.00432	CbGeAlD
Nilotinib—PDGFRA—brain—restless legs syndrome	0.000384	0.00429	CbGeAlD
Nilotinib—MAPK11—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000381	0.00899	CbGpPWpGaD
Nilotinib—PDGFRB—central nervous system—restless legs syndrome	0.000378	0.00422	CbGeAlD
Nilotinib—BRAF—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000377	0.00891	CbGpPWpGaD
Nilotinib—MAPK8—Signaling by NGF—MAP2K5—restless legs syndrome	0.000368	0.00868	CbGpPWpGaD
Nilotinib—CA1—nervous system—restless legs syndrome	0.000367	0.0041	CbGeAlD
Nilotinib—MAPK14—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.000362	0.00855	CbGpPWpGaD
Nilotinib—CA12—brain—restless legs syndrome	0.000354	0.00396	CbGeAlD
Nilotinib—CA1—central nervous system—restless legs syndrome	0.000354	0.00395	CbGeAlD
Nilotinib—ABL1—nervous system—restless legs syndrome	0.00035	0.00391	CbGeAlD
Nilotinib—PDGFRA—Focal Adhesion—MAP2K5—restless legs syndrome	0.000347	0.00819	CbGpPWpGaD
Nilotinib—MAP2K5—brain—restless legs syndrome	0.000346	0.00387	CbGeAlD
Nilotinib—ABL1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000346	0.00817	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.000345	0.00814	CbGpPWpGaD
Nilotinib—KIT—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000343	0.00811	CbGpPWpGaD
Nilotinib—CA4—spinal cord—restless legs syndrome	0.000341	0.00381	CbGeAlD
Nilotinib—CSF1R—brain—restless legs syndrome	0.000338	0.00378	CbGeAlD
Nilotinib—ABL1—central nervous system—restless legs syndrome	0.000337	0.00376	CbGeAlD
Nilotinib—MAPK14—Insulin Signaling—MAP2K5—restless legs syndrome	0.000333	0.00786	CbGpPWpGaD
Nilotinib—MAPK14—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.000329	0.00778	CbGpPWpGaD
Nilotinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000325	0.00767	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00032	0.00755	CbGpPWpGaD
Nilotinib—PDGFRB—Focal Adhesion—MAP2K5—restless legs syndrome	0.000312	0.00738	CbGpPWpGaD
Nilotinib—KIT—brain—restless legs syndrome	0.000307	0.00343	CbGeAlD
Nilotinib—ABCG2—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.000302	0.00713	CbGpPWpGaD
Nilotinib—PDGFRB—brain—restless legs syndrome	0.0003	0.00335	CbGeAlD
Nilotinib—MAPK11—Signaling by NGF—MAP2K5—restless legs syndrome	0.000293	0.00692	CbGpPWpGaD
Nilotinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000293	0.00691	CbGpPWpGaD
Nilotinib—BRAF—Signaling by NGF—MAP2K5—restless legs syndrome	0.00029	0.00685	CbGpPWpGaD
Nilotinib—CYP2D6—brainstem—restless legs syndrome	0.000288	0.00322	CbGeAlD
Nilotinib—CA4—nervous system—restless legs syndrome	0.000287	0.00321	CbGeAlD
Nilotinib—CA2—spinal cord—restless legs syndrome	0.000282	0.00316	CbGeAlD
Nilotinib—CA1—brain—restless legs syndrome	0.000281	0.00314	CbGeAlD
Nilotinib—CA4—central nervous system—restless legs syndrome	0.000276	0.00309	CbGeAlD
Nilotinib—MAPK14—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000272	0.00642	CbGpPWpGaD
Nilotinib—ABL1—brain—restless legs syndrome	0.000267	0.00299	CbGeAlD
Nilotinib—KIT—Signaling by NGF—MAP2K5—restless legs syndrome	0.000264	0.00624	CbGpPWpGaD
Nilotinib—ABCG2—spinal cord—restless legs syndrome	0.000262	0.00292	CbGeAlD
Nilotinib—PDGFRA—Signaling by NGF—MAP2K5—restless legs syndrome	0.00025	0.0059	CbGpPWpGaD
Nilotinib—MAPK8—Glucocorticoid receptor regulatory network—POMC—restless legs syndrome	0.000246	0.0058	CbGpPWpGaD
Nilotinib—CA2—nervous system—restless legs syndrome	0.000238	0.00266	CbGeAlD
Nilotinib—LCK—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.000235	0.00555	CbGpPWpGaD
Nilotinib—CA2—central nervous system—restless legs syndrome	0.000229	0.00256	CbGeAlD
Nilotinib—PDGFRB—Signaling by NGF—MAP2K5—restless legs syndrome	0.000225	0.00532	CbGpPWpGaD
Nilotinib—MAPK8—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000224	0.00529	CbGpPWpGaD
Nilotinib—CA4—brain—restless legs syndrome	0.000219	0.00245	CbGeAlD
Nilotinib—MAPK14—Signaling by NGF—MAP2K5—restless legs syndrome	0.000209	0.00494	CbGpPWpGaD
Nilotinib—CYP2B6—nervous system—restless legs syndrome	0.000203	0.00227	CbGeAlD
Nilotinib—CYP2B6—central nervous system—restless legs syndrome	0.000196	0.00219	CbGeAlD
Nilotinib—MAPK11—Glucocorticoid receptor regulatory network—POMC—restless legs syndrome	0.000196	0.00462	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—TF—restless legs syndrome	0.000192	0.00454	CbGpPWpGaD
Nilotinib—CA2—brain—restless legs syndrome	0.000182	0.00203	CbGeAlD
Nilotinib—LCK—Signaling by NGF—MAP2K5—restless legs syndrome	0.000181	0.00427	CbGpPWpGaD
Nilotinib—BRAF—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000177	0.00418	CbGpPWpGaD
Nilotinib—CYP2C8—brain—restless legs syndrome	0.000173	0.00194	CbGeAlD
Nilotinib—ABCG2—brain—restless legs syndrome	0.000168	0.00188	CbGeAlD
Nilotinib—ABCB1—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.000163	0.00386	CbGpPWpGaD
Nilotinib—CYP2B6—brain—restless legs syndrome	0.000155	0.00174	CbGeAlD
Nilotinib—CYP3A4—nervous system—restless legs syndrome	0.000154	0.00172	CbGeAlD
Nilotinib—CYP2D6—nervous system—restless legs syndrome	0.000151	0.00169	CbGeAlD
Nilotinib—CYP3A4—central nervous system—restless legs syndrome	0.000148	0.00165	CbGeAlD
Nilotinib—CYP2D6—central nervous system—restless legs syndrome	0.000145	0.00163	CbGeAlD
Nilotinib—LYN—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000145	0.00342	CbGpPWpGaD
Nilotinib—MAPK14—Glucocorticoid receptor regulatory network—POMC—restless legs syndrome	0.00014	0.0033	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000139	0.00327	CbGpPWpGaD
Nilotinib—MAPK14—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000137	0.00324	CbGpPWpGaD
Nilotinib—ABCB1—spinal cord—restless legs syndrome	0.000129	0.00144	CbGeAlD
Nilotinib—MAPK14—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.000127	0.00301	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—TF—restless legs syndrome	0.000124	0.00293	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000119	0.0028	CbGpPWpGaD
Nilotinib—CYP2D6—brain—restless legs syndrome	0.000115	0.00129	CbGeAlD
Nilotinib—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.00011	0.0026	CbGpPWpGaD
Nilotinib—ABCB1—nervous system—restless legs syndrome	0.000109	0.00121	CbGeAlD
Nilotinib—ABCB1—central nervous system—restless legs syndrome	0.000105	0.00117	CbGeAlD
Nilotinib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	9.32e-05	0.0022	CbGpPWpGaD
Nilotinib—CYP2B6—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	8.93e-05	0.00211	CbGpPWpGaD
Nilotinib—ABCB1—brain—restless legs syndrome	8.31e-05	0.000929	CbGeAlD
Nilotinib—MAPK8—Signaling Pathways—MAP2K5—restless legs syndrome	7.9e-05	0.00186	CbGpPWpGaD
Nilotinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	7.65e-05	0.00181	CbGpPWpGaD
Nilotinib—UGT1A1—Biological oxidations—POMC—restless legs syndrome	7.63e-05	0.0018	CbGpPWpGaD
Nilotinib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	7.59e-05	0.00179	CbGpPWpGaD
Nilotinib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	7.56e-05	0.00178	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	7.49e-05	0.00177	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—TF—restless legs syndrome	7.46e-05	0.00176	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—TF—restless legs syndrome	7.43e-05	0.00175	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—TF—restless legs syndrome	7.07e-05	0.00167	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MAP2K5—restless legs syndrome	6.29e-05	0.00149	CbGpPWpGaD
Nilotinib—CA3—Metabolism—POMC—restless legs syndrome	6.26e-05	0.00148	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MAP2K5—restless legs syndrome	6.23e-05	0.00147	CbGpPWpGaD
Nilotinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	6.21e-05	0.00146	CbGpPWpGaD
Nilotinib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	6.15e-05	0.00145	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TF—restless legs syndrome	6.12e-05	0.00144	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MAP2K5—restless legs syndrome	5.67e-05	0.00134	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MAP2K5—restless legs syndrome	5.37e-05	0.00127	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—TF—restless legs syndrome	5.13e-05	0.00121	CbGpPWpGaD
Nilotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	5e-05	0.00118	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MAP2K5—restless legs syndrome	4.84e-05	0.00114	CbGpPWpGaD
Nilotinib—CYP2B6—Biological oxidations—POMC—restless legs syndrome	4.74e-05	0.00112	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MAP2K5—restless legs syndrome	4.74e-05	0.00112	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MAP2K5—restless legs syndrome	4.49e-05	0.00106	CbGpPWpGaD
Nilotinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	4.06e-05	0.000958	CbGpPWpGaD
Nilotinib—CA14—Metabolism—POMC—restless legs syndrome	4.03e-05	0.000952	CbGpPWpGaD
Nilotinib—CYP2C8—Biological oxidations—POMC—restless legs syndrome	4.02e-05	0.000948	CbGpPWpGaD
Nilotinib—CA6—Metabolism—POMC—restless legs syndrome	3.93e-05	0.000927	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MAP2K5—restless legs syndrome	3.88e-05	0.000917	CbGpPWpGaD
Nilotinib—CA7—Metabolism—POMC—restless legs syndrome	3.67e-05	0.000866	CbGpPWpGaD
Nilotinib—CA12—Metabolism—POMC—restless legs syndrome	3.4e-05	0.000802	CbGpPWpGaD
Nilotinib—CYP2D6—Biological oxidations—POMC—restless legs syndrome	3.3e-05	0.000778	CbGpPWpGaD
Nilotinib—CYP2C9—Biological oxidations—POMC—restless legs syndrome	3.27e-05	0.000771	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—TF—restless legs syndrome	2.77e-05	0.000655	CbGpPWpGaD
Nilotinib—CA4—Metabolism—POMC—restless legs syndrome	2.71e-05	0.00064	CbGpPWpGaD
Nilotinib—CA2—Metabolism—POMC—restless legs syndrome	2.6e-05	0.000613	CbGpPWpGaD
Nilotinib—CA1—Metabolism—POMC—restless legs syndrome	2.49e-05	0.000588	CbGpPWpGaD
Nilotinib—CA9—Metabolism—POMC—restless legs syndrome	2.19e-05	0.000517	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—POMC—restless legs syndrome	2.16e-05	0.000509	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—POMC—restless legs syndrome	1.94e-05	0.000459	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—POMC—restless legs syndrome	1.85e-05	0.000436	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—POMC—restless legs syndrome	1.55e-05	0.000365	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	1.54e-05	0.000364	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—POMC—restless legs syndrome	1.53e-05	0.000362	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—POMC—restless legs syndrome	1.4e-05	0.000329	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—POMC—restless legs syndrome	1.32e-05	0.000312	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—POMC—restless legs syndrome	1.3e-05	0.000308	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	1.25e-05	0.000296	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—POMC—restless legs syndrome	1.19e-05	0.000281	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—POMC—restless legs syndrome	1.17e-05	0.000275	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—POMC—restless legs syndrome	1.11e-05	0.000261	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—POMC—restless legs syndrome	1.1e-05	0.000261	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—POMC—restless legs syndrome	9.55e-06	0.000225	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—POMC—restless legs syndrome	8.11e-06	0.000191	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—POMC—restless legs syndrome	6.87e-06	0.000162	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—POMC—restless legs syndrome	5.98e-06	0.000141	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—POMC—restless legs syndrome	5.64e-06	0.000133	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—POMC—restless legs syndrome	5.59e-06	0.000132	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—POMC—restless legs syndrome	3.69e-06	8.7e-05	CbGpPWpGaD
